NexImmune
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income dropped to -$32,344,392 over the previous period. Total operating expenses were $28,167,510.

Profit Margin

NexImmune, Inc. (NASDAQ:NEXI): Profit margin
2018 0 -12.83M
2019 0 -20.29M
2020 0 -31.63M
2021 0 -51.74M
2022 0 514.18M
2023 0 -32.34M

NEXI Income Statement (2018 โ€“ 2023)

2023 2022 2021 2020 2019 2018
Revenue
Revenue
000000
Cost of revenue
1.02M1.49M870.28K618.99K436.36K0
Gross profit
-1.02M-1.49M-870.28K-618.99K-436.36K0
Operating exp.
Research and development
18.25M47.14M37.45M17.83M15.17M7.99M
Selling and marketing
-12.99B00000
Total operating expenses
28.16M63.08M53.25M27.85M20.88M13.24M
Operating income
-29.19M-63.08M-53.25M-27.85M-20.88M-13.24M
Other income (expenses), net
-3.15M576.69K2.35M-2.01M339.05K136.78K
Income before tax
-32.34M-62.50M-50.90M-29.86M-20.54M-12.83M
Income tax expense
-2-576.69M843.91K1.77M-246.78K409.22K
Net income
-32.34M514.18M-51.74M-31.63M-20.29M-12.83M
Earnings per share
Basic EPS
-30.82534.29-56.67-34.76-22.53-14.25
Diluted EPS
-30.82534.29-56.67-34.76-22.53-14.25
Data sourceData sourceData sourceData source